Clinical Trial Update: Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults [Phase 1]

View source ↗

Summary

Clinical trial results from a Phase 1 study of a 10,000 EU dose of endotoxin in adults with allergic rhinitis (perennial and seasonal) and mild asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinitis Perennial
• Allergic Rhinitis Seasonal
• Asthma

Drugs mentioned

• Endotoxin (endotoxin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Seasonal | Phase 1 | Status: COMPLETED